AI app aims to keep heart patients out of the hospital
NCT ID NCT06686056
First seen Oct 31, 2025 · Last updated Jun 05, 2026 · Updated 28 times
Summary
This study tested whether an artificial intelligence (AI)-enhanced mobile app can help people with coronary heart disease manage their health after leaving the hospital. Over 1,100 participants were randomly assigned to use the app or receive usual care. The app provided reminders, tracking, and educational tips to help lower bad cholesterol and improve other health measures like blood pressure and medication adherence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY PREVENTION OF CORONARY HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, 100037, China
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.